PM Maintains by UBS -- Price Target Raised to $201.00

UBS maintained a Neutral rating for Philip Morris International Inc (PM) but raised its price target to $201.00 from $193.00, citing cautious optimism. The stock is currently trading at a 26.3% premium according to GuruFocus's GF Value™, with a GF Score™ of 81. 22 gurus hold PM, with mixed recent activity.

Original reporting
Published Oct 22, 2026, 8:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 9:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PM
Neutral
medium confidence
Mentioned
$PM
Relevance
5/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$PMNeutralLow
01

Why it matters

The price‑target increase reflects UBS's cautious optimism but does not constitute a strong new catalyst; investors may see limited short‑term price movement.

02

Market read

Analyst target adjustments are routine; this modest raise offers limited trading opportunity.

03

What to watch

Potential regulatory pressures on tobacco products and the company's shift to smoke‑free alternatives could offset the modest target raise.

Relevance 5/10Novelty 5/10Timing: today

Background

Philip Morris International is a large consumer defensive company with a market cap over $300 B, known for its tobacco products and growing focus on smoke‑free alternatives.

Company-level read

Ticker impact

$PMNeutralMedium confidence
Context

UBS raised its price target for Philip Morris International to $201, up from $193, while maintaining a Neutral rating.

Expected impact

likely modest upward pressure as the market prices in the higher target

Evidence & confidence

Analyst price‑target adjustments are a common catalyst; the change is small (4.1%) and the rating remains Neutral, so any price move is expected to be limited.

Market effects

Minimal impact on the consumer defensive sector; peers may see slight reference but no material shift.

U.S. market only; no broader regional effect.

Limited to investors tracking tobacco stocks.

Counterpoint

Some traders may view the unchanged Neutral rating as a signal to stay on the sidelines despite the higher target.

Key entities

  • UBS

    Maintains Neutral rating, raises price target to $201.

  • Philip Morris International

    Subject of the rating update.

Related articles

$PMHighAI 8/10

PMI reports third-quarter 2026 net revenue topped $11.4B

Philip Morris International (PMI) reported third-quarter 2026 net revenue of $11.4B, with smoke-free products making up over 40%. Zyn shipments grew 4.2% to 3.2B pouches. The FDA authorized 11 more Zyn Ultra variants, totaling 31. PMI plans to invest more in Zyn and transition to 20-pouch cans.

$PMMedAI 8/10

Philip Morris International Inc (PM) (Q3 2026) Earnings Call Highlights: Record $5

Philip Morris International (PM) reported Q3 2026 results with organic net revenue growth of 7.1% and adjusted operating income growth of 10.5%, exceeding $5 billion. Smoke-free products drove growth, with IQOS and Veev shipments up. The company faces cost pressures from geopolitical conflicts, impacting full-year EPS growth. Guidance was lowered to the midpoint or lower half of the range. Operating cash flow is expected to reach approximately $13.5 billion.

$THighAI 8/10

AT&T Raises 2026 Outlook as Dell AI Adoption Tops 6,500

AT&T reported Q3 revenue growth of 5.3% to $32.3B, raised 2026 adjusted EPS outlook to ~$2.40. Philip Morris saw Q3 revenue rise 5.5% to $11.4B, adjusted EPS up 5.4% to $2.36. Moody's reported 1% revenue growth to $2.023B, reaffirmed 2026 adjusted EPS forecast of $16.50-$17.00. Dell announced AI adoption by 6,500 enterprises.